Valens GroWorks Corp (CSE:VGW,OTC:VGWCF) has released an in-depth article on the chemistry of the cannabis plant and its compounds and highlighted the need for extraction. According to Valens, extraction is necessary to purify and concentrate select compounds from the cannabis plant. When done correctly, extraction can provide pure and isolated compounds free of impurities that can negatively affect a user’s experience.

There are multiple extraction methods. Most methods utilize temperature, pressure, solvents and time to access the cannabinoids, flavonoids and terpenes present in cannabis. Regardless of the extraction method, extraction results in a more concentrated product, which can be dangerous if the plant contains toxins or heavy metals before being processed.


As one of the largest third-party cannabis extraction companies in Canada, Valens tests, analyzes and produces cannabis extracts for medical and recreational cannabis distributors. The company offers large capacity, in-house quality testing and various extraction services to other licensed producers such as Canopy Growth (TSX:WEED), Harvest One (TSXV:HVT) and Tilray (NASDAQ:TLRY), among others. Valens is currently able to process 240,000 kilograms of cannabis and meticulously tests its products for purity and safety throughout the process.

Overall, Valens believes that the future of the cannabis industry is moving towards extraction due to its versatility. Cannabis extracts can be packaged into oil capsules, vape cartridges and edibles, among other products. By offering several different extraction methods, Valens can ethically and sustainably produce various products for its clients with a wide array of cannabinoid and terpene profiles.

“The future of cannabis in Canada is coming and we are going to be at the forefront,”  said Valens CEO Tyler Robson.

To view the full article, click here.

Click here to connect with Valens GroWorks Corp (CSE:VGW,OTC:VGWCF)  for an Investor Presentation. 

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less